<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200523047554N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-06-02</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of violence  prevention and management educational program</public_title>
      <acronym></acronym>
      <scientific_title>The effect of educational program on nurses attitude, self-confidence and practice related to prevention and management of patients violence</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/48455</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: Accidental allocation of sections to intervention and control groups, Blinding description: The present study is a semi-experimental one-way blind study (the statistical advisor professor of data type which belongs to which group will be unaware) before and after with the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Violence in the workplace nurses.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Nurses in the intervention group will be tested for "attitudes toward violence management", "confidence in dealing with aggression" and "practice in dealing with violence" at the beginning and before the start of the first training session, and then nursing staff. 3 sessions, one session per week, each session for 8 hours, in the training classes of one of the two hospitals of the test group, in the classes of the training program for prevention and management of workplace violence that will be held by the project manager, under the training of skills Communication with patients, prevention and violence management skills of patients and patients will be provided at work, meetings will be held in the form of lectures, group discussions, scenarios and role-playing. The content of the meetings, which is based on the instructions, includes; Different definitions and types of violence in the workplace, risk factors related to patient violence, ways to prevent and manage violence in the workplace, the response of health care personnel to how to communicate properly with the patient and how to follow up and to satisfy the victims of violence. It is violence. Eight weeks after the last session, all nurses in the test group will take the "Attitude Towards Violence Management" and "confidence in dealing with aggression" and "practice in dealing with violence" tests. Intervention 2: Control group: Nurses in the control group will be tested at the beginning and at the same time as the test group on "Attitudes Towards Violence Management", "confidence in dealing with aggression", and "practice in dealing with violence". These people will not attend training sessions, and 8 weeks after the final training session for the test group, all nurses in the control group will be tested for "Attitudes Towards Violence Management "confidence in dealing with aggression" and  "practice in dealing with violence".will be taken.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on the main consequence

When:
22 - 8 - 2020

To whom:
Researchers working in academic and scientific institutions

Conditions:
The data obtained are analyzed by SPSS software version 16 and the use of appropriate statistical methods of descriptive statistics (distribution tables, mean and standard deviation) and inferential statistics (independent t-test, analysis of variance and chi-square). .

Where to obtain:
mousavi.shm74@gmail.com

How to obtain:
mousavi.shm74@gmail.com

Comments:
..</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Hossein Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Meybod. Bafrooiya. Imam Khomeini Street . Alley 94. Subsidiary 2</address>
        <city>Meybod</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8963133819</zip>
        <telephone>+98 35 3233 2376</telephone>
        <email>mousavi.shm74@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyyedhossein Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Yazd . Meybod. Bafrooiya. Imam Khomeini street . Alley 94 Subsidiary 2</address>
        <city>Meybod</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8963133819</zip>
        <telephone>+98 35 3233 2376</telephone>
        <email>mousavi.shm74@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Employment in the emergency department
The desire to participate in research
At least 6 months of work experience in the emergency department</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of participating in violence prevention and management training courses at work</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Nurses in the intervention group will be tested for "attitudes toward violence management", "confidence in dealing with aggression" and "practice in dealing with violence" at the beginning and before the start of the first training session, and then nursing staff. 3 sessions, one session per week, each session for 8 hours, in the training classes of one of the two hospitals of the test group, in the classes of the training program for prevention and management of workplace violence that will be held by the project manager, under the training of skills Communication with patients, prevention and violence management skills of patients and patients will be provided at work, meetings will be held in the form of lectures, group discussions, scenarios and role-playing. The content of the meetings, which is based on the instructions, includes; Different definitions and types of violence in the workplace, risk factors related to patient violence, ways to prevent and manage violence in the workplace, the response of health care personnel to how to communicate properly with the patient and how to follow up and to satisfy the victims of violence. It is violence. Eight weeks after the last session, all nurses in the test group will take the "Attitude Towards Violence Management" and "confidence in dealing with aggression" and "practice in dealing with violence" tests.</i_keyword>
      <i_keyword>Control group: Nurses in the control group will be tested at the beginning and at the same time as the test group on "Attitudes Towards Violence Management", "confidence in dealing with aggression", and "practice in dealing with violence". These people will not attend training sessions, and 8 weeks after the final training session for the test group, all nurses in the control group will be tested for "Attitudes Towards Violence Management "confidence in dealing with aggression" and  "practice in dealing with violence".will be taken</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Attitude score in the questionnaire "Attitude towards violence management". Timepoint: Before the start of the intervention and 2 months after the end of the last intervention session. Method of measurement: Questionnaire on "Attitudes Towards Violence Management".</prim_outcome>
      <prim_outcome>Self-confidence score in the questionnaire "Confidence in dealing with aggression". Timepoint: Before the start of the intervention and 2 months after the end of the last intervention session. Method of measurement: Questionnaire on "Confidence in dealing with aggression".</prim_outcome>
      <prim_outcome>Practice score in the Questionnaire  "Practice Toward Workplace Violence Questionnaire". Timepoint: Before the start of the intervention and 2 months after the end of the last intervention session. Method of measurement: Questionnaire  "Practice Toward Workplace Violence Questionnaire".</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-28</approval_date>
        <contact_name>Institutional research ethics committee school of nursing and midwifery &amp; rehabilitation</contact_name>
        <contact_address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat Street. Tohid Square. Tehran .Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
